UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)
OF THE
SECURITIES ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission
File Number: 0-28498
PARADIGM
MEDICAL INDUSTRIES, INC.
(Exact
name of registrant as specified in its charter)
2355
South 1070 West
Salt Lake
City, Utah 84119
(Address,
including zip code, and telephone number, including area code, of
registrant's
principal executive offices)
Common
Stock, par value $.001 per share
(Title of
each class of securities covered by this form)
None
(Titles
of all other classes of securities for which a duty to file reports
under
Section
13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate
or suspend the duty to file reports:
|
Rule
12g-4(a)(1)
|
o
|
|
Rule
12g-4(a)(2)
|
x
|
|
Rule
12h-3(b)(1)(i)
|
o
|
|
Rule
12h-3(b)(1)(ii)
|
o
|
|
Rule
15d-6
|
o
|
Approximate number of
holders of record as of the certification or notice
date: 471
Pursuant to the
requirements of the Securities Exchange Act of 1934, Paradigm Medical
Industries, Inc. has caused this certification/notice to be signed on its behalf
by the undersigned duly authorized person.
|
/s/ Stephen
L. Davis
|
Date: August
10, 2009
|
By:
|
Stephen
L. Davis
|
|
|
President,
Chief Executive Officer and
Treasurer
|
Instruction: This
form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and
Regulations under the Securities Exchange Act of 1934. The registrant
shall file with the Commission three copies of Form 15, one of which shall be
manually signed. It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person. The name and title of
the person signing the form shall be typed or printed under the
signature.